Individualizing PSA Monitoring Among Older Prostate Cancer Survivors

Ying Shi; Kathy Z Fung; W John Boscardin; Sarah Ngo; Stephen J Freedland; Melisa L Wong; Louise C Walter

doi:10.1007/s11606-018-4334-9

Individualizing PSA Monitoring Among Older Prostate Cancer Survivors

J Gen Intern Med. 2018 May;33(5):602-604. doi: 10.1007/s11606-018-4334-9.

Authors

Ying Shi^{1

2}, Kathy Z Fung^{1

2}, W John Boscardin^{1

2

3}, Sarah Ngo^{1

2}, Stephen J Freedland^{4

5}, Melisa L Wong^{1

2

6}, Louise C Walter^{7

8}

Affiliations

¹ Division of Geriatrics, San Francisco VA Health Care System 181G, 4150 Clement Street, San Francisco, CA, 94121, USA.
² Division of Geriatrics, University of California, San Francisco, San Francisco, CA, USA.
³ Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.
⁴ Center for Integrated Research on Cancer and Lifestyle, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
⁵ Division of Urology, Durham VA Medical Center, Durham, NC, USA.
⁶ Division of Hematology/Oncology, University of California, San Francisco, San Francisco, CA, USA.
⁷ Division of Geriatrics, San Francisco VA Health Care System 181G, 4150 Clement Street, San Francisco, CA, 94121, USA. [email protected].
⁸ Division of Geriatrics, University of California, San Francisco, San Francisco, CA, USA. [email protected].

No abstract available

Keywords: PSA monitoring; aging; prostate cancer; survivorship.

Publication types

Research Support, N.I.H., Extramural

MeSH terms

Aged
Cancer Survivors / statistics & numerical data*
Early Detection of Cancer / methods
Early Detection of Cancer / statistics & numerical data
Humans
Longitudinal Studies
Male
Mass Screening / statistics & numerical data*
Neoplasm Recurrence, Local / diagnosis
Neoplasm Recurrence, Local / epidemiology*
Prostate-Specific Antigen / blood*
Prostatic Neoplasms / classification
Prostatic Neoplasms / epidemiology*
Prostatic Neoplasms / therapy

Substances

Prostate-Specific Antigen

Publication types

MeSH terms

Substances

Grants and funding